News & Updates
Filter by Specialty:
Ecopipam cuts Tourette tics
Children and adolescents with Tourette syndrome (TS) may benefit from ecopipam, a first-in-class selective dopamine-1 (D1) receptor antagonist, as it reduced the number of tics and level of daily interference in a post hoc analysis of the phase IIb D1AMOND trial.
Ecopipam cuts Tourette tics
25 Apr 2024
Tandem cycling benefits Parkinson’s patients, their care partners
A pilot study presented at AAN 2024 revealed that a tandem cycling programme may improve the overall health and wellbeing of individuals with Parkinson’s disease (PD) and their care partners.
Tandem cycling benefits Parkinson’s patients, their care partners
24 Apr 2024
Lower VTE risk seen in atopic dermatitis vs other inflammatory diseases
Atopic dermatitis (AD) does not seem to induce an increase in the risk of venous thromboembolism (VTE) when considering underlying risk factors, suggests a study. Moreover, patients with AD show a lower VTE risk than those with rheumatoid arthritis (RA), Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA), or ankylosing spondylitis (AS).
